camptothecin has been researched along with Ventricular Dysfunction, Left in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchini, G; Cortes, J; Henning, JW; Rugo, HS; Untch, M | 1 |
1 review(s) available for camptothecin and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer.
Topics: Alopecia; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Camptothecin; Fatigue; Female; Humans; Immunoconjugates; Lung Diseases, Interstitial; Nausea; Neutropenia; Trastuzumab; Ventricular Dysfunction, Left; Vomiting | 2022 |